Literature DB >> 5572656

Sustained-release quinidine (Kinidin Durules) in maintaining sinus rhythm after electroversion of atrial dysrhythmias.

L Resnekov, D Gibson, S Waich, J Muir, L McDonald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5572656      PMCID: PMC487168          DOI: 10.1136/hrt.33.2.220

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  9 in total

1.  "CARDIOVERSION" OF ARRHYTHMIAS. I.

Authors:  B LOWN
Journal:  Mod Concepts Cardiovasc Dis       Date:  1964-07

2.  EXPERIENCE WITH "CARDIOVERSION" OF ATRIAL FIBRILLATION AND FLUTTER.

Authors:  J J MORRIS; Y KONG; W C NORTH; H D MCINTOSH
Journal:  Am J Cardiol       Date:  1964-07       Impact factor: 2.778

3.  QUANTITATIVE DETERMINATION OF QUINIDINE IN PLASMA.

Authors:  G CRAMER; B ISAKSSON
Journal:  Scand J Clin Lab Invest       Date:  1963       Impact factor: 1.713

4.  New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge.

Authors:  B LOWN; R AMARASINGHAM; J NEUMAN
Journal:  JAMA       Date:  1962-11-03       Impact factor: 56.272

5.  Clinical and experimental investigation of a new type of oral prolonged-action tablet (Duretter).

Authors:  R SANNERSTEDT
Journal:  Acta Med Scand       Date:  1960-07-15

6.  THE TECHNIQUE OF CARDIOVERSION.

Authors:  B LOWN; R KLEIGER; G WOLFF
Journal:  Am Heart J       Date:  1964-02       Impact factor: 4.749

7.  Experiences with the photofluorometric determination of quinidine in blood.

Authors:  A L EDGAR; M SOKOLOW
Journal:  J Lab Clin Med       Date:  1950-09

8.  Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion.

Authors:  L Resnekov; L McDonald
Journal:  Br Heart J       Date:  1967-11

9.  The use of quinidine in cardioversion.

Authors:  M Rossi; B Lown
Journal:  Am J Cardiol       Date:  1967-02       Impact factor: 2.778

  9 in total
  4 in total

1.  Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.

Authors:  G M Frigo; E Perucca; M Teggia-Droghi; G Gatti; A Mussini; J Salerno
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

2.  Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm.

Authors:  T Södermark; B Jonsson; A Olsson; L Orö; H Wallin; O Edhag; A Sjögren; M Danielsson; G Rosenhamer
Journal:  Br Heart J       Date:  1975-05

3.  Absorption of quinidine from an enteric-coated preparation.

Authors:  D Fremstad; O G Nilsen; J Amlie; L Storstein; B Olsson; S Jacobsen
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

4.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Authors:  Lucie Valembois; Etienne Audureau; Andrea Takeda; Witold Jarzebowski; Joël Belmin; Carmelo Lafuente-Lafuente
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.